+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Bovine Serum Albumin Market, by End-User, by Application - Industry Analysis and Forecast to 2019-2025

  • PDF Icon


  • 125 Pages
  • September 2019
  • Region: Global
  • Blueweave Consulting & Research Pvt Ltd
  • ID: 4990203
The Global Bovine Serum Albumin Market projected to a value of USD 242 million in the year 2018 and is expected to grow at a CAGR of 4.1% from 2019, to reach a value of USD 317 million by the year 2025. The bovine serum albumin market is driven by rising utilization of blood plasma items in the nourishment business, propels in bovine-like blood gathering and preparing, and expanded interest for creature meat and creature protein among the human populace. Significant limitations of the market are ascending in bovine diseases and illnesses, bringing about decreased generation, and increment in the inclination for alternative items.

Different drivers of the bovine serum albumin market incorporate augmenting the by-product of cell culture technology, expanded interest for ox-like serum egg whites bovine serum albumin as an excipient in the pharmaceutical business, and improvement in the inventory network and conveyance organize in the worldwide bovine serum albumin market.

The life sciences segment from the end-user section is projected to be the fastest-growing segment of the bovine serum albumin market during the forecast period

The life sciences section in the market is anticipated to be the quickest developing section, as broad research is being led in the pharmaceutical and biotechnology enterprises. Additionally, bovine serum albumin is utilized in the generation of antibodies, medicate conveyance and planning of mammalian cell culture media. Because of the progressions in nanotechnology, sedate conveyance, as an application, is developing quickly in the life sciences section.

The dry form segment from the form section is projected to be the fastest-growing segment bovine serum albumin market during the forecast period

The dry form segment, from the form section of the bovine serum albumin market, is anticipated to hold the most significant market share in the bovine serum market during the conjecture time frame. The dry type of bovine serum albumin is generally favored over the fluid-structure by producers due to its more extended timeframe of realistic usability. This quality of the dry structure has likewise prompted the ascent in imports and fares of bovine serum albumin.

Asia Pacific and North American regions hold a significant amount of share in the bovine serum albumin market

The Asia Pacific and North American nations are seeing expanding interest for bovine serum albumin for the pharmaceutical and symptomatic industry. The development of the bovine serum albumin market in the North American district spikes from the popularity of red meat and its items, close by the dynamic changes in the meat handling industry in nations, for example, the US and Canada. The Asia Pacific region has a developing opportunity for the utilization of BSA in the pharmaceutical and specialized businesses, as the pharmaceutical business is sprouting in this area. China is the second-biggest pharmaceutical market over the globe. For the treatment of ceaseless illnesses, the exploration and advancement segment is seeing high ventures that will essentially drive the interest in creative medications.

Global Bovine Serum Albumin Market: Competitive Insight

Itoham Yonekyu Holdings Inc (Japan), Proliant Biologicals (US), Kraeber & Co Gmbh (Germany), Thermo Fisher Scientific (US), Bio-Rad Laboratories, Inc (US), Merck KGAA (Germany), Rockland Immunochemicals Inc (US), Bio-Techne Corporation (US), Prospec-Tany Technogene Ltd (Israel), and LGC Group (UK), (Singapore), Rocky mountain biologicals (US), BelHealth investment partners, LLC (US), are some of the major players in the global bovine serum albumin market.

This product will be delivered within 2 business days.

Table of Contents

1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology3. Executive Summary
4. Industry Insights
4.1. Industry Value Chain Analysis
4.2. Industry Impact and Forces
4.2.1. Growth Drivers
4.2.2. Challenges
4.2.3. Trends
4.3. Product Developments & Innovations
4.4. Technology Landscape
4.5. Regulatory Framework
4.6. Company Share Analysis, 2018
4.7. Growth potential Analysis
4.8. Strategic Outlook
4.9. Porter’s analysis
4.10. PESTEL analysis
5. Global Bovine Serum Albumin Market Overview
5.1. Market Size & Forecast
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By End-User Diagnostic Industry Pharmaceutical Industry Research Institutes Others
5.2.2. By Application Vaccine Production In-Vitro Diagnostics Biochemical Assays Others
5.2.3. By Region North America Europe Asia Pacific South America Middle East & Africa
6. North America Bovine Serum Albumin Market Overview
6.1. Market Size & Forecast, 2015-2025
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By End-User
6.2.2. By Application
6.2.3. By Country US Canada
7. Europe Bovine Serum Albumin Market Overview
7.1. Market Size & Forecast, 2015-2025
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By End-User
7.2.2. By Application
7.2.3. By Country Germany UK France Italy Spain
8. Asia Pacific Bovine Serum Albumin Market Overview
8.1. Market Size & Forecast, 2015-2025
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By End-User
8.2.2. By Application
8.2.3. By Country China India Japan Southeast Asia
9. Latin America Bovine Serum Albumin Market Overview
9.1. Market Size & Forecast, 2015-2025
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By End-User
9.2.2. By Application
9.2.3. By Country Brazil Argentina
10. Middle East & Africa Bovine Serum Albumin Market Overview
10.1. Market Size & Forecast, 2015-2025
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
10.2.1. By End-User
10.2.2. By Application
10.2.3. By Country Saudi Arabia UAE South Africa
11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, SWOT Analysis and Strategic Outlook)
11.1. Itoham Yonekyu Holdings Inc.
11.2. Proliant Biologicals
11.3. Kraeber & Co Gmbh
11.4. Thermo Fisher Scientific
11.5. Bio-Rad Laboratories, Inc.
11.6. Merck KGAA
11.7. Rockland Immunochemicals Inc.
11.8. Bio-Techne Corporation
11.9. Prospec-Tany Technogene Ltd.
11.10. LGC Group
11.11. Rocky mountain biologicals
11.12. BelHealth investment partners, LLC
11.13. Other Prominent Players
*Financial Details Not Be Captured in Case of Unlisted Companies
The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable